Medical network - on February 24 for the implementation of the state council about the opinions of the drug review of medical equipment examination and approval system reform "(guo fa [2015] 44) the relevant requirements, the state food and drug supervision and administration bureau drafted on the drug registration again the announcement of relevant matters (draft)", is to solicit opinions from the public. Please make amendments to feedback by email before April 13, 2017 to the administration of state food and drug supervision and administration. 

 

Email: hxypc@cfda.gov.cn 

 

Attachment: about drugs registration again the announcement of relevant matters (draft) 

 

The food and drug supervision administration office 

 

On February 13, 2017 

 

The attachment 

 

About drugs registration again the announcement of relevant matters 

 

(draft) 

 

To implement the "state council on drug review of medical equipment examination and approval system reform opinions (guo fa [2015] 44), improve the system of drug registration again, now the matters related to notice the following: 

 

In the drug approval documents shall specify the period of validity, the all products specifications are not listed or import drug, cannot perform continuous responsibility of quality, efficacy and adverse drug reaction, since the date of this announcement, the drug will not be registered again, approval number (the imported drug registration certificate "the pharmaceutical products registration certificate) will be cancelled after the expiration. 

 

Notice is hereby given that the. 

 

The food and drug supervision bureau 

 

In 2017,